{"id":"W1995357901","doi":"10.3109/10428194.2010.490312","title":"Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts","year":2010,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Pharmacology; Medicine; Bone marrow; Leukemia; Drug; Therapeutic index; Myeloid leukemia; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009231142,0.001140377,0.001776026,0.001311294,0.0005647057,0.00019372,0.0004573173,0.001077587,0.0001288481],"category_scores_gemma":[0.0005592886,0.001043302,0.000309645,0.001199858,0.0008687483,0.0007233417,0.0003077058,0.0005380019,0.00004413341],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01176296,"about_ca_system_score_gemma":0.007905026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005503441,"about_ca_topic_score_gemma":0.001546397,"domain_scores_codex":[0.9937081,0.0002757551,0.001948234,0.001594695,0.001060028,0.001413226],"domain_scores_gemma":[0.995886,0.0006229997,0.0006768737,0.001424759,0.0005024204,0.0008869785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00250464,0.0007585145,0.08980388,0.0008814923,0.0005899154,0.0009260657,0.003096015,0.0003157702,0.7822003,0.008743032,0.0009202413,0.1092601],"study_design_scores_gemma":[0.08931558,0.00261368,0.6133664,0.001077828,0.0007067203,0.001611812,0.00135268,0.06199304,0.2188239,0.001434256,0.005375478,0.0023287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922935,0.000843519,0.0001952394,0.0002625029,0.0003260387,0.002023055,0.00007818527,0.0002462387,0.003731709],"genre_scores_gemma":[0.9936993,0.0009311185,0.002059347,0.0004004248,0.0005980843,0.0003316289,0.0006319683,0.0001933216,0.001154776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5633765,"threshold_uncertainty_score":0.9992017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01513441191351091,"score_gpt":0.2812551573835176,"score_spread":0.2661207454700067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}